BFM
DYN icon

Boothbay Fund Management’s Dyne Therapeutics DYN Stock Holding History

Boothbay Fund Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59,900
Closed -$627K – 1533
2025
Q1 		$627K Buy
+59,900
New +$857K 0.02% 780
2024
Q1 		– Sell
-145,600
Closed -$1.94M – 1658
2023
Q4 		$1.94M Buy
145,600
+90,700
+165% +$886K 0.05% 502
2023
Q3 		$492K Buy
+54,900
New +$591K 0.01% 1038

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boothbay Fund Management's DYN Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 30,600 shares worth $680K. The stake represents 0.01% of the portfolio and ranks #1318 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in DYN as recently as Q3 2025.

Boothbay Fund Management first reported a position in DYN in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.2M in Q1 2025. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Boothbay Fund Management held 30,600 shares of Dyne Therapeutics worth $680K as of Q2 2026.
  • Dyne Therapeutics was a new Boothbay Fund Management position in Q2 2026.
  • Dyne Therapeutics made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1318 holding.
  • Boothbay Fund Management first reported a position in Dyne Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • Boothbay Fund Management's Dyne Therapeutics position peaked at $1.2M in Q1 2025.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.